{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:30:24Z","timestamp":1772753424123,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s12010-023-04603-w","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T08:02:22Z","timestamp":1688976142000},"page":"1481-1492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["CDCA8 Facilitates Tumor Proliferation and Predicts a Poor Prognosis in Hepatocellular Carcinoma"],"prefix":"10.1007","volume":"196","author":[{"given":"Yunlong","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"key":"4603_CR1","doi-asserted-by":"publisher","first-page":"790916","DOI":"10.3389\/fonc.2022.790916","volume":"12","author":"W Wang","year":"2022","unstructured":"Wang, W., et al. (2022). The potential roles of exosomal non-coding RNAs in hepatocellular carcinoma. Frontiers in Oncology, 12, 790916.","journal-title":"Frontiers in Oncology"},{"issue":"29","key":"4603_CR2","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.3748\/wjg.v26.i29.4240","volume":"26","author":"Z Niu","year":"2020","unstructured":"Niu, Z., et al. (2020). Role of long noncoding RNA-mediated competing endogenous RNA regulatory network in hepatocellular carcinoma. World Journal of Gastroenterology, 26(29), 4240\u20134260.","journal-title":"World Journal of Gastroenterology"},{"issue":"12","key":"4603_CR3","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/s41388-017-0070-6","volume":"37","author":"MX Liu","year":"2018","unstructured":"Liu, M. X., et al. (2018). Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma. Oncogene, 37(12), 1637\u20131653.","journal-title":"Oncogene"},{"issue":"2","key":"4603_CR4","first-page":"389","volume":"11","author":"G Qi","year":"2021","unstructured":"Qi, G., et al. (2021). CDCA8, targeted by MYBL2, promotes malignant progression and olaparib insensitivity in ovarian cancer. American Journal of Cancer Research, 11(2), 389\u2013415.","journal-title":"American Journal of Cancer Research"},{"issue":"24","key":"4603_CR5","doi-asserted-by":"publisher","first-page":"11097","DOI":"10.1111\/jcmm.17032","volume":"25","author":"X Cui","year":"2021","unstructured":"Cui, X., et al. (2021). Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma. Journal of Cellular and Molecular Medicine, 25(24), 11097\u201311112.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"2","key":"4603_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41419-021-03405-4","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang, X., et al. (2021). Double-targeting CDCA8 and E2F1 inhibits the growth and migration of malignant glioma. Cell Death & Disease, 12(2), 146.","journal-title":"Cell Death & Disease"},{"key":"4603_CR7","doi-asserted-by":"publisher","first-page":"784183","DOI":"10.3389\/fonc.2022.784183","volume":"12","author":"S Wan","year":"2022","unstructured":"Wan, S., et al. (2022). Overexpression of CDCA8 predicts poor prognosis and promotes tumor cell growth in prostate cancer. Frontiers in Oncology, 12, 784183.","journal-title":"Frontiers in Oncology"},{"key":"4603_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2019.04.006","volume":"703","author":"Y Bu","year":"2019","unstructured":"Bu, Y., et al. (2019). CDCA8 is a key mediator of estrogen-stimulated cell proliferation in breast cancer cells. Gene, 703, 1\u20136.","journal-title":"Gene"},{"issue":"9","key":"4603_CR9","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1158\/0008-5472.CAN-06-4705","volume":"67","author":"S Hayama","year":"2007","unstructured":"Hayama, S., et al. (2007). Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis. Cancer Research, 67(9), 4113\u20134122.","journal-title":"Cancer Research"},{"issue":"3","key":"4603_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/pros.23940","volume":"80","author":"M Gruber","year":"2020","unstructured":"Gruber, M., Handle, F., & Culig, Z. (2020). The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells. The Prostate, 80(3), 267\u2013273.","journal-title":"The Prostate"},{"issue":"3","key":"4603_CR11","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1080\/21655979.2022.2044249","volume":"13","author":"J Yang","year":"2022","unstructured":"Yang, J., & Yang, Y. (2022). Long noncoding RNA endogenous bornavirus-like nucleoprotein acts as an oncogene by regulating microRNA-655-3p expression in T-cell acute lymphoblastic leukemia. Bioengineered, 13(3), 6409\u20136419.","journal-title":"Bioengineered"},{"key":"4603_CR12","doi-asserted-by":"publisher","first-page":"104295","DOI":"10.1016\/j.cellimm.2021.104295","volume":"361","author":"C Ma","year":"2021","unstructured":"Ma, C., Zhang, Q., & Greten, T. F. (2021). MDSCs in liver cancer: A critical tumor-promoting player and a potential therapeutic target. Cellular Immunology, 361, 104295.","journal-title":"Cellular Immunology"},{"key":"4603_CR13","doi-asserted-by":"publisher","first-page":"153459","DOI":"10.1016\/j.prp.2021.153459","volume":"223","author":"C Hu","year":"2021","unstructured":"Hu, C., et al. (2021). miR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8. Pathology, Research and Practice, 223, 153459.","journal-title":"Pathology, Research and Practice"},{"issue":"6","key":"4603_CR14","doi-asserted-by":"publisher","first-page":"6977","DOI":"10.18632\/oncotarget.24059","volume":"9","author":"NN Phan","year":"2018","unstructured":"Phan, N. N., et al. (2018). Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient. Oncotarget, 9(6), 6977\u20136992.","journal-title":"Oncotarget"},{"key":"4603_CR15","doi-asserted-by":"publisher","first-page":"e9078","DOI":"10.7717\/peerj.9078","volume":"8","author":"X Gao","year":"2020","unstructured":"Gao, X., et al. (2020). Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells. PeerJ, 8, e9078.","journal-title":"PeerJ"},{"issue":"37","key":"4603_CR16","doi-asserted-by":"publisher","first-page":"22423","DOI":"10.1074\/jbc.M115.642710","volume":"290","author":"C Dai","year":"2015","unstructured":"Dai, C., et al. (2015). Transcriptional activation of human CDCA8 gene regulated by transcription factor NF-Y in embryonic stem cells and cancer cells. The Journal of Biological Chemistry, 290(37), 22423\u201322434.","journal-title":"The Journal of Biological Chemistry"},{"issue":"40","key":"4603_CR17","doi-asserted-by":"publisher","first-page":"21137","DOI":"10.1074\/jbc.M116.736173","volume":"291","author":"L Li","year":"2016","unstructured":"Li, L., et al. (2016). Hepatic loss of borealin impairs postnatal liver development, regeneration, and hepatocarcinogenesis. The Journal of Biological Chemistry, 291(40), 21137\u201321147.","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"4603_CR18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/jb\/mvab071","volume":"170","author":"X Wang","year":"2022","unstructured":"Wang, X., et al. (2022). MiR-133a-3p inhibits the malignant progression of oesophageal cancer by targeting CDCA8. Journal of Biochemistry, 170(6), 689\u2013698.","journal-title":"Journal of Biochemistry"},{"issue":"7155","key":"4603_CR19","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nature06046","volume":"448","author":"D Santamar\u00eda","year":"2007","unstructured":"Santamar\u00eda, D., et al. (2007). Cdk1 is sufficient to drive the mammalian cell cycle. Nature, 448(7155), 811\u2013815.","journal-title":"Nature"},{"key":"4603_CR20","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.2147\/CMAR.S200907","volume":"11","author":"Y Deng","year":"2019","unstructured":"Deng, Y., et al. (2019). Sp1 contributes to radioresistance of cervical cancer through targeting G2\/M cell cycle checkpoint CDK1. Cancer Management and Research, 11, 5835\u20135844.","journal-title":"Cancer Management and Research"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-023-04603-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-023-04603-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-023-04603-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T11:11:20Z","timestamp":1708341080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-023-04603-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["4603"],"URL":"https:\/\/doi.org\/10.1007\/s12010-023-04603-w","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]},"assertion":[{"value":"19 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Tianjin Medical University Cancer Institute & Hospital and written consent approval was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Yes","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Yes","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}